Laronidase: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Laronidase. Educational only — not medical advice.
Labeled uses
ALDURAZYME ® is indicated for the treatment of: adult and pediatric patients with Hurler and Hurler-Scheie forms of Mucopolysaccharidosis I (MPS I) and patients with the Scheie form of MPS I who have moderate to severe symptoms.
Source: FDA labeling via NIH DailyMed (set a80ac249…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.